Ibrutinib alone and in combination with rituximab for older patients with chronic lymphocytic leukaemia
Ibrutinib alone and in combination with rituximab for older patients with chronic lymphocytic leukaemia
Stem cell transplant after CAR T-cell therapy reduces relapses in acute lymphocytic leukaemia
CAR T-Cell therapy with concurrent ibrutinib for chronic lymphocytic leukaemia
Latest results from JULIET: Tisagenlecleucel in adults with DLBCL
CD19-directed CAR T-cell therapy for patients with relapsed B-cell acute lymphocytic leukaemia
Latest analysis of the ELIANA trial for acute lymphocytic leukaemia
Ibrutinib outperforms chemoimmunotherapy in older patients with chronic lymphocytic leukaemia
Latest advances in acute lymphoblastic leukaemia and paediatrics in HARMONY
Immunotherapy in older patients
The SIOG 2018 conference
The missions and future of SIOG
Can we cure advanced metastatic melanoma patients?